SKYRIZI

Class [005]
Pharmaceutical preparations and substances for the treatment of viral diseases, namely herpes, hepatitis, Acquired Immune Deficiency Syndrome (AIDS); pharmaceutical preparations and substances for the treatment of metabolic diseases and disorders, namely diabetes, bulimia nervosa, anorexia, obesity, hypothyroidism, hypoglycemia, gout, osteoarthritis, muscular dystrophy and anemia; pharmaceutical preparations and substances for the treatment of diseases, disorders and infections of the endocrine system, namely growth and thyroid disorders; pharmaceutical preparations and substances for the treatment of the musculoskeletal system, namely, connective tissue disease, bone diseases, spinal diseases, back pain, fractures, sprains and cartilage injuries; pharmaceutical preparations and substances for the treatment of cardiovascular and cardiopulmonary diseases and disorders; pharmaceutical preparations and substances for the treatment of genitourinary diseases, namely, urological diseases, infertility, sexually transmitted diseases, incontinence, inflammatory pelvic diseases and sexual dysfunction; pharmaceutical preparations and substances for the treatment of oncological diseases and disorders; pharmaceutical preparations and substances for the treatment of ophthalmic, respiratory and gastrointestinal diseases and disorders; pharmaceutical preparations and substances for the treatment of neurological diseases and disorders, namely, Alzheimer's, Huntington's Disease, cerebral palsy, brain injury, spinal cord injury and seizure disorders; pharmaceutical hormonal preparations, namely, corticosteroids, hormone replacement therapy preparations, oral contraceptives, thyroid hormone preparations; pharmaceutical preparations for use in dermatology, namely, dermatitis, skin pigmentation diseases, acne, bacterial skin infections, fungal skin infections, viral skin infections and parasitic skin infections; pharmaceutical preparations and substances for the treatment of psychiatric diseases, namely, mood disorders, anxiety disorders, cognitive disorders and schizophrenia; pharmaceutical preparations and substances for the treatment of immunologic diseases, namely, autoimmune diseases and immunologic deficiency syndromes